Fontan-associated Liver Disease in Adults: What a Cardiologist Needs to Know. A Comprehensive Review for Clinical Practitioners

Nowadays most patients with a univentricular heart after Fontan repair survive until adulthood. One of the hallmarks of Fontan circulation is permanently elevated central venous pressure, which leads to congestive hepatopathy. Subsequently, liver fibrosis, cirrhosis, or hepatocellular carcinoma may...

Full description

Bibliographic Details
Main Authors: Aleksandra Cieplucha, Werner Budts, Marc Gewillig, Alexander Van De Bruaene
Format: Article
Language:English
Published: Radcliffe Medical Media 2022-11-01
Series:US Cardiology Review
Online Access:https://www.uscjournal.com/articleindex/usc.2022.02
_version_ 1797199988312244224
author Aleksandra Cieplucha
Werner Budts
Marc Gewillig
Alexander Van De Bruaene
author_facet Aleksandra Cieplucha
Werner Budts
Marc Gewillig
Alexander Van De Bruaene
author_sort Aleksandra Cieplucha
collection DOAJ
description Nowadays most patients with a univentricular heart after Fontan repair survive until adulthood. One of the hallmarks of Fontan circulation is permanently elevated central venous pressure, which leads to congestive hepatopathy. Subsequently, liver fibrosis, cirrhosis, or hepatocellular carcinoma may occur, all of them constituting an entity called Fontan-associated liver disease (FALD). Given that these complications convey poor prognosis, the need for life-long hepatic surveillance is not in doubt. Many serum biomarkers and sophisticated imaging techniques have been proposed to avoid invasive liver biopsy in this cohort, but none proved to be a relevant surrogate of liver fibrosis seen in histopathological specimens. The surveillance models proposed to date require an extensive diagnostic work-up, which can be problematic, particularly in resource-depleted countries. Moreover, the question of combined heart–liver transplant is gaining more attention in the Fontan cohort. The aim of this study is to provide practical information on the pathophysiology of FALD and to propose a simplified framework for the routine assessment of liver status in Fontan patients that would be helpful in the decision-making process.
first_indexed 2024-03-07T17:40:02Z
format Article
id doaj.art-7431af02a2b1416d87f7bd69bf595f69
institution Directory Open Access Journal
issn 1758-3896
1758-390X
language English
last_indexed 2024-04-24T07:24:30Z
publishDate 2022-11-01
publisher Radcliffe Medical Media
record_format Article
series US Cardiology Review
spelling doaj.art-7431af02a2b1416d87f7bd69bf595f692024-04-20T16:03:07ZengRadcliffe Medical MediaUS Cardiology Review1758-38961758-390X2022-11-011610.15420/usc.2022.02Fontan-associated Liver Disease in Adults: What a Cardiologist Needs to Know. A Comprehensive Review for Clinical PractitionersAleksandra Cieplucha0Werner Budts1Marc Gewillig2Alexander Van De Bruaene3First Department of Cardiology, Poznan University of Medical Sciences, Poznan, PolandDivision of Congenital and Structural Cardiology, University Hospitals Leuven, Belgium; Department of Cardiovascular Sciences, KU Leuven, BelgiumDepartment of Cardiovascular Sciences, KU Leuven, Belgium; Division of Pediatric Cardiology, University Hospitals Leuven, BelgiumDivision of Congenital and Structural Cardiology, University Hospitals Leuven, Belgium; Department of Cardiovascular Sciences, KU Leuven, BelgiumNowadays most patients with a univentricular heart after Fontan repair survive until adulthood. One of the hallmarks of Fontan circulation is permanently elevated central venous pressure, which leads to congestive hepatopathy. Subsequently, liver fibrosis, cirrhosis, or hepatocellular carcinoma may occur, all of them constituting an entity called Fontan-associated liver disease (FALD). Given that these complications convey poor prognosis, the need for life-long hepatic surveillance is not in doubt. Many serum biomarkers and sophisticated imaging techniques have been proposed to avoid invasive liver biopsy in this cohort, but none proved to be a relevant surrogate of liver fibrosis seen in histopathological specimens. The surveillance models proposed to date require an extensive diagnostic work-up, which can be problematic, particularly in resource-depleted countries. Moreover, the question of combined heart–liver transplant is gaining more attention in the Fontan cohort. The aim of this study is to provide practical information on the pathophysiology of FALD and to propose a simplified framework for the routine assessment of liver status in Fontan patients that would be helpful in the decision-making process.https://www.uscjournal.com/articleindex/usc.2022.02
spellingShingle Aleksandra Cieplucha
Werner Budts
Marc Gewillig
Alexander Van De Bruaene
Fontan-associated Liver Disease in Adults: What a Cardiologist Needs to Know. A Comprehensive Review for Clinical Practitioners
US Cardiology Review
title Fontan-associated Liver Disease in Adults: What a Cardiologist Needs to Know. A Comprehensive Review for Clinical Practitioners
title_full Fontan-associated Liver Disease in Adults: What a Cardiologist Needs to Know. A Comprehensive Review for Clinical Practitioners
title_fullStr Fontan-associated Liver Disease in Adults: What a Cardiologist Needs to Know. A Comprehensive Review for Clinical Practitioners
title_full_unstemmed Fontan-associated Liver Disease in Adults: What a Cardiologist Needs to Know. A Comprehensive Review for Clinical Practitioners
title_short Fontan-associated Liver Disease in Adults: What a Cardiologist Needs to Know. A Comprehensive Review for Clinical Practitioners
title_sort fontan associated liver disease in adults what a cardiologist needs to know a comprehensive review for clinical practitioners
url https://www.uscjournal.com/articleindex/usc.2022.02
work_keys_str_mv AT aleksandracieplucha fontanassociatedliverdiseaseinadultswhatacardiologistneedstoknowacomprehensivereviewforclinicalpractitioners
AT wernerbudts fontanassociatedliverdiseaseinadultswhatacardiologistneedstoknowacomprehensivereviewforclinicalpractitioners
AT marcgewillig fontanassociatedliverdiseaseinadultswhatacardiologistneedstoknowacomprehensivereviewforclinicalpractitioners
AT alexandervandebruaene fontanassociatedliverdiseaseinadultswhatacardiologistneedstoknowacomprehensivereviewforclinicalpractitioners